IDFC LIMITED: Best Opportunity to Buy on yearly High Breakout

IDFC Limited is a financial services holding company based in India. It operates through various subsidiaries, including IDFC First Bank (formerly IDFC Bank), IDFC AMC (asset management company), IDFC Alternatives (private equity and infrastructure), and IDFC Securities.

IDFC Limited is a good buy for 2023 due to its strong fundamentals, customised credit card business, focus on online lending, and exposure in corporate funding, the company offers a strong liability franchise, retail franchise, and an attractive return on embedded value of around 20%.Additionally, India's penetration of life insurance is still low, offering potential for growth. Furthermore, the company has recently been cleared by the Securities and Exchange Board of India, adding to the stability of the stock The stock has also given a HEAD & SHOULDER resistance breakout and bullish candle stick pattern, and is currently trading in the ₹87 range. Market experts are expecting the stock to hit ₹100 and ₹120 in the short to medium term,. Additionally, IDFC Limited has delivered a whopping 65% return to its shareholders in the last six months.

Technically the stock looks good for buy at this level which is recently cross above year high & Head & Shoulder breakout.Very good buy above Rs.88 With stop loss rs. 80. Short  medium term target Rs. 120.

Happy investing.

UFLEX: STRONG UPMOVE JOURNEY POSSIBLE

UFLEX(CMP-678)  starts correction OCT'21 & consolidate FROM NOV'21 TO 7TH MAR'22. Last week was able to break out with good volume START TO BUY AT THIS LEVEL & DIPS UP UP TO 660 WITH SL 620 TARGET 840.

PRICE TRADES AVOVE IMPORTANT MOVING AVERAGES AS SHOWN BELOW:

TECHNICAL BUY OF THIS PHARMA PLAYER- Dishman Carbogen Amcis Ltd:

Dishman Carbogen Amcis Ltd is a fully integrated CRAMS player working with global pharmaceutical innovators, has a global presence with development and manufacturing facilities across Europe, India, and China. We provide end-to-end, integrated, high-value, niche CRAMS offering, right from process research and development to late-stage clinical and commercial manufacturing facilities along with the supply of Active Pharmaceutical Ingredients (API) to innovator pharmaceutical companies. In the weekly chart, this stock breaks out above Rs.213 forming an Inverted Head and Shoulder. Buy at CMP-237 with target-400 within one year maintaining the stop loss 200

Technical Buy Wipro Limited

Buy  IT Giant Wipro Limited for multi fold Return(CMP-469.20)

From Jan 21 Wipro limited was in correction phase as flat movement .last week created a new high after good result.Buy at this level & dips @ 450 for the conservative target to 525 short term & then 600.
Support Level are   450/430/400

Bhansali Engineering-A Technically Bullish Stock

 Bhansali Engineering is Ready to Huge Up move(CMP-163.80)

On daily chart Bhansali Engineering has formed an ideal symmetrical Triangle.On 7/4/21 price just cross downtrend resistance line .If price sustains above Rs.160.It would be a good opportunity to buy this Bullish trending stock Targeting Rs.230 Short to medium term keeping Stop loss Rs.153.

Happy investing.